The expression was disease‐stage dependent, as PCs from patients with the precursor states smoldering MM (sMM) and monoclonal gammopathy of undetermined significance (MGUS) exhibited significantly lower TOPK expression when compared to PCs from patients with myeloma requiring treatment. The gene discussed is PBK; the disease is plasma cell myeloma.